Clarus Therapeutics Holdings, Inc. (CRXTQ)

USD 0.0

(0.0%)

Total Assets Summary of Clarus Therapeutics Holdings, Inc.

  • Clarus Therapeutics Holdings, Inc.'s latest annual total assets in 2021 was 51.7 Million USD , up 166.54% from previous year.
  • Clarus Therapeutics Holdings, Inc.'s latest quarterly total assets in 2022 Q2 was 48.94 Million USD , up 34.0% from previous quarter.
  • Clarus Therapeutics Holdings, Inc. reported annual total assets of 19.4 Million USD in 2020, down 0.0% from previous year.
  • Clarus Therapeutics Holdings, Inc. reported quarterly total assets of 36.52 Million USD for 2022 Q1, down 0.0% from previous quarter.
  • Clarus Therapeutics Holdings, Inc. reported quarterly total assets of 51.7 Million USD for 2021 FY, up 166.54% from previous quarter.

Annual Total Assets Chart of Clarus Therapeutics Holdings, Inc. (2021 - 2020)

Historical Annual Total Assets of Clarus Therapeutics Holdings, Inc. (2021 - 2020)

Year Total Assets Total Assets Growth
2021 51.7 Million USD 166.54%
2020 19.4 Million USD 0.0%

Peer Total Assets Comparison of Clarus Therapeutics Holdings, Inc.

Name Total Assets Total Assets Difference
AstraZeneca PLC 100.97 Billion USD 99.949%
Bristol-Myers Squibb Company PFD CONV 2 95.15 Billion USD 99.946%
CSPC Pharmaceutical Group Limited 6.52 Billion USD 99.207%
Novartis AG 99.94 Billion USD 99.948%
PT Kalbe Farma Tbk. 1.75 Billion USD 97.06%